We serve Chemical Name:1-(4-propan-2-yl-2-sulfanylidene-1,3-thiazolidin-3-yl)propan-1-one CAS:102831-92-5 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:1-(4-propan-2-yl-2-sulfanylidene-1,3-thiazolidin-3-yl)propan-1-one
CAS.NO:102831-92-5
Synonyms:1-(4-propan-2-yl-2-sulfanylidene-1,3-thiazolidin-3-yl)propan-1-one
Molecular Formula:C9H15NO2S
Molecular Weight:201.28600
HS Code:2934999090
Physical and Chemical Properties:
Melting point:N/A
Boiling point:252.242ºC at 760 mmHg
Density:1.148 g/cm3
Index of Refraction:1.534
PSA:61.63000
Exact Mass:201.08200
LogP:1.50260
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like 1-(4-propan-2-yl-2-sulfanylidene-1,3-thiazolidin-3-yl)propan-1-one chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,1-(4-propan-2-yl-2-sulfanylidene-1,3-thiazolidin-3-yl)propan-1-one physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,1-(4-propan-2-yl-2-sulfanylidene-1,3-thiazolidin-3-yl)propan-1-one Use and application,1-(4-propan-2-yl-2-sulfanylidene-1,3-thiazolidin-3-yl)propan-1-one technical grade,usp/ep/jp grade.
Related News: During Covid-19, the company has helped fill a void in meeting API demand for medicines used to treat patients with the virus. In April of last year, Wavelength expanded its production of API for three generic drugs— sedative midazolam, muscle relaxant cisatracurium, and paralytic rocuronium — to help keep up with hospital demand. ({(-)-trans-1-[(2-amino-6-hydroxy-9H-purine-9-yl)methyl]-2-methylcyclopropyl}oxy)methylphosphonic acid manufacturers While reactions requiring the use of metal catalysts may necessitate heating to temperatures of 160oC, and/or cooling to -60oC or lower, enzyme-catalyzed reactions instead run at temperatures in the region of ~10 – 40oC. (3-ethyl-1,1-dioxo-1λ6-thiomorpholin-4-yl)-(5-nitro-furan-2-ylmethylene)-amine suppliers Grégoire Boutonnet, Chief Operating Officer of NOVA, said: “I am thrilled to be joining the NOVA team at this exciting period of growth as we launch the Jinkō platform towards wider adoption in the clinical trial development space. ethyl-(4-nitro-but-3-enyl)-ether vendor & factory.
